Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Liver Int. 2019 Dec 15;40(3):590–597. doi: 10.1111/liv.14309

Figure 3. Correlation of PA oxidation with metabolic syndrome features and liver fat.

Figure 3

The 6-hour palmitic acid CPDR in NAFLD subjects is not correlated with (A) HOMA-IR, (B) BMI, (C) Adipo-IR, (D) Glucose, (E) Triglycerides, (F) Liver fat percent by 1H-MRS or (G) ALT, (H) LSM.